J. Daly Richard's Insider Trades & SAST Disclosures
J. Daly Richard's most recent trade in Broadridge Financial Solutions, Inc. was a trade of 604 Common Stock done at an average price of $244.7 . Disclosure was reported to the exchange on April 1, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern J. Daly Richard.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
Showing you 100 results sorted by most recent dates.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Broadridge Financial Solut... | Richard J. Daly | Director, Executive Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 244.72 per share. | 01 Apr 2025 | 604 | 103,489 (0%) | 0% | 244.7 | 147,811 | Common Stock |
| Catalyst Pharmaceuticals Inc | Richard J. Daly | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2025 | 4,000 | 271,338 (0%) | 0% | - | Common Stock, par value $0.001 per share | |
| Catalyst Pharmaceuticals Inc | Richard J. Daly | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2025 | 4,000 | 2,234,753 | - | - | Restricted Stock Units | |
| Catalyst Pharmaceuticals Inc | Richard J. Daly | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 14 Feb 2025 | 1,574 | 269,764 (0%) | 0% | - | Common Stock, par value $0.001 per share | |
| Broadridge Financial Solut... | Richard J. Daly | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2025 | 4,241 | 4,241 | - | - | Stock Option (Right to Buy) | |
| Catalyst Pharmaceuticals Inc | Richard J. Daly | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2025 | 42,105 | 277,938 (0%) | 0% | - | Common Stock, par value $0.001 per share | |
| Catalyst Pharmaceuticals Inc | Richard J. Daly | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2025 | 42,105 | 2,238,753 | - | - | Restricted Stock Units | |
| Catalyst Pharmaceuticals Inc | Richard J. Daly | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 02 Jan 2025 | 10,600 | 267,338 (0%) | 0% | - | Common Stock, par value $0.001 per share | |
| Catalyst Pharmaceuticals Inc | Richard J. Daly | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Dec 2024 | 1,333 | 2,280,858 | - | - | Restricted Stock Units | |
| Catalyst Pharmaceuticals Inc | Richard J. Daly | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Dec 2024 | 1,333 | 236,157 (0%) | 0% | - | Common Stock, par value $0.001 per share | |
| Catalyst Pharmaceuticals Inc | Richard J. Daly | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 27 Dec 2024 | 324 | 235,833 (0%) | 0% | - | Common Stock, par value $0.001 per share | |
| Catalyst Pharmaceuticals Inc | Richard J. Daly | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2024 | 491,160 | 2,222,172 | - | - | Options to purchase common stock | |
| Catalyst Pharmaceuticals Inc | Richard J. Daly | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2024 | 60,019 | 2,282,191 | - | - | Restricted Stock Units | |
| Broadridge Financial Solut... | Richard J. Daly | Director, Executive Chairman | Gift of securities by or to the insider at price $ 0.00 per share. | 21 Nov 2024 | 1,000 | 104,093 (0%) | 0% | 0 | Common Stock | |
| Broadridge Financial Solut... | Richard J. Daly | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Sep 2024 | 14,510 | 0 | - | - | Stock Option (Right to Buy) | |
| Broadridge Financial Solut... | Richard J. Daly | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 117.34 per share. | 06 Sep 2024 | 14,510 | 127,031 (0%) | 0% | 117.3 | 1,702,603 | Common Stock |
| Broadridge Financial Solut... | Richard J. Daly | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 207.66 per share. | 06 Sep 2024 | 12,900 | 105,093 (0%) | 0% | 207.7 | 2,678,849 | Common Stock |
| Broadridge Financial Solut... | Richard J. Daly | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 207.66 per share. | 06 Sep 2024 | 9,038 | 117,993 (0%) | 0% | 207.7 | 1,876,855 | Common Stock |
| Broadridge Financial Solut... | Richard J. Daly | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 1,239 | 112,521 (0%) | 0% | 0 | Common Stock | |
| Catalyst Pharmaceuticals Inc | Richard J. Daly | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.01 per share. | 04 Jun 2024 | 40,000 | 252,147 (0%) | 0% | 4.0 | 160,400 | Common stock, par value $0.001 per share |
| Catalyst Pharmaceuticals Inc | Richard J. Daly | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2024 | 40,000 | 1,731,012 | - | - | Options to purchase common stock | |
| Catalyst Pharmaceuticals Inc | Richard J. Daly | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 15.98 per share. | 04 Jun 2024 | 17,323 | 234,824 (0%) | 0% | 16.0 | 276,735 | Common stock, par value $0.001 per share |
| Broadridge Financial Solut... | Richard J. Daly | Director, Executive Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 203.23 per share. | 01 Apr 2024 | 438 | 111,282 (0%) | 0% | 203.2 | 89,015 | Common Stock |
| Broadridge Financial Solut... | J. Daly Richard | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 5,086 | 5,086 | - | - | Stock Option (Right to Buy) | |
| Catalyst Pharmaceuticals Inc | J. Daly Richard | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 4,000 | 1,771,012 | - | - | Restricted Stock Units | |
| Catalyst Pharmaceuticals Inc | J. Daly Richard | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2024 | 4,000 | 213,333 (0%) | 0% | - | Common stock, par value $0.001 per share | |
| Catalyst Pharmaceuticals Inc | Daly J. Richard | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 15 Feb 2024 | 1,186 | 212,147 (0%) | 0% | - | Common stock, par value $0.001 per share | |
| Catalyst Pharmaceuticals Inc | Richard Daly J. | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2024 | 1,365,319 | 1,564,486 | - | - | Options to purchase common stock | |
| Catalyst Pharmaceuticals Inc | Richard J. Daly | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2024 | 210,526 | 1,775,012 | - | - | Restricted Stock Units | |
| Catalyst Pharmaceuticals Inc | Daly Richard J. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Dec 2023 | 1,333 | 199,167 | - | - | Restricted Stock Units | |
| Catalyst Pharmaceuticals Inc | Daly Richard J. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Dec 2023 | 1,333 | 209,333 (0%) | 0% | - | Common Stock, par value $0.001 per share | |
| Catalyst Pharmaceuticals Inc | Daly J. Richard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Dec 2023 | 60,000 | 200,500 | - | - | Options to purchase common stock | |
| Catalyst Pharmaceuticals Inc | J. Richard Daly | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.13 per share. | 07 Dec 2023 | 60,000 | 208,000 (0%) | 0% | 1.1 | 67,800 | Common Stock, par value $0.001 per share |
| Broadridge Financial Solut... | Richard J. Daly | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 185.40 per share. | 28 Aug 2023 | 8,297 | 111,720 (0%) | 0% | 185.4 | 1,538,268 | Common Stock |
| Broadridge Financial Solut... | Richard J. Daly | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Aug 2023 | 43,527 | 14,510 | - | - | Stock Option (Right to Buy) | |
| Broadridge Financial Solut... | Richard J. Daly | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 117.34 per share. | 21 Aug 2023 | 43,527 | 155,287 (0%) | 0% | 117.3 | 5,107,458 | Common Stock |
| Broadridge Financial Solut... | Richard J. Daly | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 178.29 per share. | 21 Aug 2023 | 39,600 | 120,017 (0%) | 0% | 178.3 | 7,060,434 | Common Stock |
| Broadridge Financial Solut... | Richard J. Daly | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 98.31 per share. | 21 Aug 2023 | 36,780 | 192,067 (0%) | 0% | 98.3 | 3,615,842 | Common Stock |
| Broadridge Financial Solut... | Richard J. Daly | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Aug 2023 | 36,780 | 0 | - | - | Stock Option (Right to Buy) | |
| Broadridge Financial Solut... | Richard J. Daly | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 178.29 per share. | 21 Aug 2023 | 32,450 | 159,617 (0%) | 0% | 178.3 | 5,785,634 | Common Stock |
| Broadridge Financial Solut... | Richard J. Daly | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 178.82 per share. | 18 Aug 2023 | 31,565 | 111,760 (0%) | 0% | 178.8 | 5,644,343 | Common Stock |
| Broadridge Financial Solut... | Richard J. Daly | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 179.16 per share. | 18 Aug 2023 | 9,484 | 0 (0%) | 0% | 179.2 | 1,699,156 | Common Stock |
| Broadridge Financial Solut... | Richard J. Daly | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 178.91 per share. | 18 Aug 2023 | 5,000 | 15,000 (0%) | 0% | 178.9 | 894,560 | Common Stock |
| Broadridge Financial Solut... | Richard J. Daly | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 179.19 per share. | 18 Aug 2023 | 5,000 | 15,000 (0%) | 0% | 179.2 | 895,969 | Common Stock |
| Broadridge Financial Solut... | Richard J. Daly | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2023 | 898 | 143,325 (0%) | 0% | 0 | Common Stock | |
| Catalyst Pharmaceuticals Inc | Richard J. Daly | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 May 2023 | 50,000 | 260,500 | - | - | Options to purchase common stock | |
| Catalyst Pharmaceuticals Inc | Richard J. Daly | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.79 per share. | 12 May 2023 | 50,000 | 148,000 (0%) | 0% | 0.8 | 39,500 | Common Stock, par value $0.001 per share |
| Broadridge Financial Solut... | Richard J. Daly | Director, Executive Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 146.57 per share. | 01 Apr 2023 | 742 | 142,427 (0%) | 0% | 146.6 | 108,755 | Common Stock |
| Broadridge Financial Solut... | Richard J. Daly | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2023 | 5,714 | 5,714 | - | - | Stock Option (Right to Buy) | |
| Catalyst Pharmaceuticals Inc | Richard J. Daly | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2023 | 4,000 | 310,500 | - | - | Restricted Stock Units | |
| Catalyst Pharmaceuticals Inc | Richard J. Daly | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2023 | 4,000 | 98,000 (0%) | 0% | - | Common Stock, par value $0.001 per share | |
| Catalyst Pharmaceuticals Inc | Richard J. Daly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Dec 2022 | 15,000 | 310,500 | - | - | Options to purchase common stock | |
| Catalyst Pharmaceuticals Inc | Richard J. Daly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Dec 2022 | 4,000 | 314,500 | - | - | Restricted Stock Units | |
| Catalyst Pharmaceuticals Inc | Richard J. Daly | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Dec 2022 | 1,334 | 295,500 | - | - | Restricted Stock Units | |
| Catalyst Pharmaceuticals Inc | Richard J. Daly | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Dec 2022 | 1,334 | 94,000 (0%) | 0% | - | Common Stock, par value $0.001 per share | |
| Broadridge Financial Solut... | Richard J. Daly | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 175.39 per share. | 26 Aug 2022 | 64,300 | 143,169 (0%) | 0% | 175.4 | 11,277,577 | Common Stock |
| Broadridge Financial Solut... | Richard J. Daly | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 98.31 per share. | 26 Aug 2022 | 36,780 | 180,335 (0%) | 0% | 98.3 | 3,615,842 | Common Stock |
| Broadridge Financial Solut... | Richard J. Daly | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Aug 2022 | 36,780 | 36,780 | - | - | Stock Option (Right to Buy) | |
| Broadridge Financial Solut... | Richard J. Daly | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 93.88 per share. | 26 Aug 2022 | 35,817 | 216,152 (0%) | 0% | 93.9 | 3,362,500 | Common Stock |
| Broadridge Financial Solut... | Richard J. Daly | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Aug 2022 | 35,817 | 0 | - | - | Stock Option (Right to Buy) | |
| Broadridge Financial Solut... | Richard J. Daly | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 175.04 per share. | 26 Aug 2022 | 8,683 | 207,469 (0%) | 0% | 175.0 | 1,519,872 | Common Stock |
| Broadridge Financial Solut... | Richard J. Daly | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 176.34 per share. | 26 Aug 2022 | 1,985 | 0 (0%) | 0% | 176.3 | 350,035 | Common Stock |
| Catalyst Pharmaceuticals Inc | Richard J. Daly | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Aug 2022 | 40,000 | 296,834 | - | - | Options to purchase common stock | |
| Catalyst Pharmaceuticals Inc | Richard J. Daly | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.53 per share. | 24 Aug 2022 | 40,000 | 92,666 (0%) | 0% | 2.5 | 101,200 | Common stock, par value $0.001 per share |
| Broadridge Financial Solut... | Richard J. Daly | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2022 | 1,523 | 143,555 (0%) | 0% | 0 | Common Stock | |
| Broadridge Financial Solut... | Richard J. Daly | Director, Executive Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 156.31 per share. | 01 Apr 2022 | 5,921 | 142,032 (0%) | 0% | 156.3 | 925,512 | Common Stock |
| Catalyst Pharmaceuticals Inc | Richard J. Daly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2022 | 12,000 | 336,834 | - | - | Restricted Stock Units | |
| Broadridge Financial Solut... | Richard J. Daly | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2022 | 4,117 | 4,117 | - | - | Stock Option (Right to Buy) | |
| Catalyst Pharmaceuticals Inc | Richard J. Daly | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.35 per share. | 25 Jan 2022 | 50,000 | 52,666 (0%) | 0% | 3.4 | 167,500 | Common stock, par value $0.001 per share |
| Catalyst Pharmaceuticals Inc | Richard J. Daly | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2022 | 50,000 | 324,834 | - | - | Options to purchase common stock | |
| Catalyst Pharmaceuticals Inc | Richard J. Daly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Dec 2021 | 20,000 | 374,834 | - | - | Options to purchase common stock | |
| Catalyst Pharmaceuticals Inc | Richard J. Daly | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Dec 2021 | 1,333 | 354,834 | - | - | Restricted Stock Units | |
| Catalyst Pharmaceuticals Inc | Richard J. Daly | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Dec 2021 | 1,333 | 2,666 (0%) | 0% | - | Common Stock, par value $0.001 per share | |
| Broadridge Financial Solut... | Richard J. Daly | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Oct 2021 | 73,560 | 73,560 | - | - | Stock Option (Right to Buy) | |
| Broadridge Financial Solut... | Richard J. Daly | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 98.31 per share. | 07 Oct 2021 | 73,560 | 212,904 (0%) | 0% | 98.3 | 7,231,684 | Common Stock |
| Broadridge Financial Solut... | Richard J. Daly | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 168.43 per share. | 07 Oct 2021 | 73,300 | 147,953 (0%) | 0% | 168.4 | 12,346,080 | Common Stock |
| Broadridge Financial Solut... | Richard J. Daly | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 93.88 per share. | 07 Oct 2021 | 8,349 | 221,253 (0%) | 0% | 93.9 | 783,804 | Common Stock |
| Broadridge Financial Solut... | Richard J. Daly | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Oct 2021 | 8,349 | 35,817 | - | - | Stock Option (Right to Buy) | |
| Broadridge Financial Solut... | Richard J. Daly | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 93.88 per share. | 05 Oct 2021 | 99,100 | 227,606 (0%) | 0% | 93.9 | 9,303,508 | Common Stock |
| Broadridge Financial Solut... | Richard J. Daly | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Oct 2021 | 99,100 | 44,166 | - | - | Stock Option (Right to Buy) | |
| Broadridge Financial Solut... | Richard J. Daly | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 165.50 per share. | 05 Oct 2021 | 88,793 | 139,344 (0%) | 0% | 165.5 | 14,695,499 | Common Stock |
| Broadridge Financial Solut... | Richard J. Daly | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 164.02 per share. | 05 Oct 2021 | 44,543 | 128,506 (0%) | 0% | 164.0 | 7,305,845 | Common Stock |
| Broadridge Financial Solut... | Richard J. Daly | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 67.32 per share. | 05 Oct 2021 | 39,000 | 206,167 (0%) | 0% | 67.3 | 2,625,480 | Common Stock |
| Broadridge Financial Solut... | Richard J. Daly | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Oct 2021 | 39,000 | 3,747 | - | - | Stock Option (Right to Buy) | |
| Broadridge Financial Solut... | Richard J. Daly | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 164.02 per share. | 05 Oct 2021 | 33,118 | 173,049 (0%) | 0% | 164.0 | 5,431,942 | Common Stock |
| Broadridge Financial Solut... | Richard J. Daly | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 67.32 per share. | 05 Oct 2021 | 3,747 | 231,353 (0%) | 0% | 67.3 | 252,248 | Common Stock |
| Broadridge Financial Solut... | Richard J. Daly | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Oct 2021 | 3,747 | 0 | - | - | Stock Option (Right to Buy) | |
| Broadridge Financial Solut... | Richard J. Daly | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 165.50 per share. | 05 Oct 2021 | 3,216 | 228,137 (0%) | 0% | 165.5 | 532,257 | Common Stock |
| Broadridge Financial Solut... | Richard J. Daly | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2021 | 12,157 | 167,167 (0%) | 0% | 0 | Common Stock | |
| Broadridge Financial Solut... | Richard J. Daly | Director, Executive Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 154.92 per share. | 01 Apr 2021 | 15,168 | 155,010 (0%) | 0% | 154.9 | 2,349,827 | Common Stock |
| Broadridge Financial Solut... | Richard J. Daly | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2021 | 4,849 | 4,849 | - | - | Stock Option (Right to Buy) | |
| Broadridge Financial Solut... | Richard J. Daly | Director, Executive Chairman | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Feb 2021 | 2,700 | 2,700 (0%) | 0% | 0 | Common Stock | |
| Broadridge Financial Solut... | Richard J. Daly | Director, Executive Chairman | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Feb 2021 | 2,700 | 170,178 (0%) | 0% | 0 | Common Stock | |
| Catalyst Pharmaceuticals Inc | Richard J. Daly | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Dec 2020 | 1,333 | 1,333 (0%) | 0% | - | Common Stock, par value $0.001 per share | |
| Catalyst Pharmaceuticals Inc | Richard J. Daly | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Dec 2020 | 1,333 | 326,167 | - | - | Restricted Stock Units | |
| Broadridge Financial Solut... | Richard J. Daly | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 127.88 per share. | 24 Sep 2020 | 8,446 | 180,690 (0%) | 0% | 127.9 | 1,080,100 | Common Stock |
| Broadridge Financial Solut... | Richard J. Daly | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 128.75 per share. | 24 Sep 2020 | 7,812 | 172,878 (0%) | 0% | 128.8 | 1,005,801 | Common Stock |
| Broadridge Financial Solut... | Richard J. Daly | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 129.82 per share. | 21 Sep 2020 | 7,979 | 189,136 (0%) | 0% | 129.8 | 1,035,862 | Common Stock |
| Broadridge Financial Solut... | Richard J. Daly | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Sep 2020 | 35,246 | 42,747 | - | - | Stock Option (Right to Buy) | |
| Broadridge Financial Solut... | Richard J. Daly | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 67.32 per share. | 17 Sep 2020 | 35,246 | 227,531 (0%) | 0% | 67.3 | 2,372,761 | Common Stock |
| Broadridge Financial Solut... | Richard J. Daly | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 132.86 per share. | 17 Sep 2020 | 30,416 | 197,115 (0%) | 0% | 132.9 | 4,041,109 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges